Real-time fluorescent quantitative polymerase chain reaction study of polo-like kinase-1 in pterygia

Journal of International Medical Research

Volumn 37, Issue 6, 2009, Pages 1851-1858

  Lu, H ^a   Lou, Ding Hua ^a   Zhu, L L ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Polo like kinase 1; Pterygia; Real time fluorescent quantitative polymerase chain reaction

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; POLO LIKE KINASE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MALE; PTERYGIUM; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 74949093756     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700621     Document Type: Article

References (27)

1. Di Girolamo N, Coroneo M, Wakefield D: Epidermal growth factor receptor signaling is partially responsible for the increased matrix metalloproteinase-1 expression in ocular epithelial cells after UVB radiation. Am J Pathol 2005; 167: 489-503.
2. Wong VA, Law FC: Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Opthalmology 1999; 106: 1512-1515.
3. Sánchez-Thorin JC, Rocha G, Yelin JB: Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 1998; 82: 661-665.
4. Tan DT, Liu YP, Sun L: Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000; 41: 1684-1686.
5. Bau DT, Chiang CC, Tsai YY, et al: Evaluation of transforming growth factor and vascular endothelial growth factor polymorphisms in Taiwan Chinese patients with pterygium. Eur J Ophthalmol 2008; 18: 21-26.
6. Schellini SA, Hoyama E, Oliveira DE, et al: Matrix metalloproteinase-9 expression in pterygium. Arq Bras Oftalmol 2006; 69: 161-164.
7. Di Girolamo N, Wakefield D, Coroneo MT: UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest Ophthalmol Vis Sci 2006; 47: 2430-2437.
8. Tan DT, Tang WY, Liu YP, et al: Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84: 212-216.
9. Weinstein O, Rosenthal G, Zirkin H, et al: Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002; 16: 619-621.
10. Sunkel CE, Glover DM: polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 1988; 89: 25-38.
11. Eckerdt F, Yuan J, Strebhardt K: Polo-like kinases and oncogenesis. Oncogene 2005; 24: 267-276.
12. Liu X, Erikson RL: Polo-like kinase (Plk) 1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 2003; 100: 5789-5794.
13. Guan R, Tapang P, Leverson JD, et al: Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals. Cancer Res 2005; 65: 2698-2704.
14. Yamada S, Ohira M, Horie H, et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 2004; 23: 5901-5911.
15. Ito Y, Miyoshi E, Sasaki N, et al: Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer 2004; 90: 414-418.
16. Peiretti E, Dessì S, Mulas C, et al: Modulation of cholesterol homeostasis by antiproliferative drugs in human pterygium fibroblasts. Invest Ophthalmol Vis Sci 2007; 48: 3450-3458.
17. Tsai YY, Cheng YW, Lee H, et al: P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium. Mol Vis 2005; 11: 50-55.
18. Shimmura S, Ishioka M, Hanada K, et al: Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci 2000; 41: 1364-1369.
19. Chowers I, Pe'er J, Zamir E, et al: Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001; 108: 985-988.
20. Weichert W, Ullrich A, Schmidt M, et al: Expression patterns of polo-like kinase 1 in human gastric cancer. Cancer Sci 2006; 97: 271-276.
21. Toyoshima-Morimoto F, Taniguchi E, Nishida E: Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 2002; 3: 341-348.
22. Sumara I, Vorlaufer E, Stukenberg PT, et al: The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol Cell 2002; 9: 515-525.
23. Golan A, Yudkovsky Y, Hershko A: The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J Biol Chem 2002; 277: 15552-15557.
24. Zhou T, Aumais JP, Liu X, et al: A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell 2003; 5: 127-138.
25. Bu Y, Yang Z, Li Q, et al: Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells. Oncology 2008; 74: 198-206.
26. Kaiser K, Rabodonirina M, Picot S: Real time quantitative PCR and RT-PCR for analysis of Pneumocystis carinii hominis. J Microbiol Methods 2001; 45: 113-118.
27. Hu LH, Chen FH, Li YR, et al: Real-time determination of human telomerase reverse transcriptase mRNA in gastric cancer. World J Gastroenterol 2004; 10: 3514-3517.